Medline Inc. - Class A common stock (MDLN)
Healthcare › Medical Instruments & Supplies
Price History
Feb 27, 2026 — May 8, 2026Investment Snapshot
- P/E of 29.6 — elevated valuation multiple
- Piotroski F-Score 6/9 — moderate financial health
- ROE of 10.8% — below-average profitability
- Revenue growing at 11% annually
Medline Inc. - Class A common stock (MDLN) is a Healthcare company operating in Medical Instruments & Supplies, listed on the NASDAQ , with a market capitalisation of $34.3 billion . Key value metrics: P/E ratio 29.6, P/B ratio 3.69, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Medline Inc. - Class A common stock — Fundamental Analysis Summary
Medline Inc. - Class A common stock (MDLN) trades at a trailing P/E of 29.6x — 18% above the Healthcare sector average of 25.2x. At a P/B of 3.69x, the stock trades at 3.69x book value.
On financial health, MDLN shows a moderate Piotroski F-Score of 6/9, and modest return on equity of 10.8% (sector average: -20.6%), and elevated leverage with a debt-to-equity ratio of 1.79.
StockPik's composite Value Score for MDLN is 64/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MDLN reports a moderate gross margin of 26.4% (sector average: 40.1%) and a modest operating margin of 7.8%.
MDLN shows revenue growing at 11% year-over-year, with earnings growing at 1%.